Castle biosciences to present at the 20th annual needham virtual healthcare conference

Friendswood, texas--(business wire)---- $cstl #castlebiosciences--castle biosciences, inc. (nasdaq: cstl), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced that derek maetzold, president and chief executive officer, is scheduled to present a company overview at the 20th annual needham virtual healthcare conference on april 12, 2021, at 4:30 p.m. eastern time. a live audio webcast of the company's presentation will be available by visiting ca
CSTL Ratings Summary
CSTL Quant Ranking